J&P – Avax Sa:企業の戦略・SWOT・財務分析

◆英語タイトル:J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3011
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ギリシャ
◆産業分野:Construction
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

J&P – Avax Sa – Strategy, SWOT and Corporate Finance Report
Summary

J&P – Avax Sa – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

J&P – Avax S.A. (Avax) is a construction company. The company carries out construction, concession management, and real estate development, renewable energy systems and energy trading, motor checking of vehicles and facility management activities. The company executes construction work for civil engineering projects such as hospitals, sports facilities, hotels, banks, educational facilities, garages, airports, buildings, olympic sports facilities, and other civil engineering projects. Its infrastructure projects consist of bridges, railroad, roads, and harbor. The company also carries out development activities for energy and industrial projects including construction of power plant, natural gas and petrochemical project, and environmental plants. The company owns branch offices in Albania, Bulgaria, Romania, Cyprus, Poland, Lebanon, Jordan, Malta and Qatar. Avax is headquartered in Marousi, Greece.

Scope

- Detailed information on J&P – Avax Sa required for business and competitor intelligence needs
- A study of the major internal and external factors affecting J&P – Avax Sa in the form of a SWOT analysis
- An in-depth view of the business model of J&P – Avax Sa including a breakdown and examination of key business segments
- Intelligence on J&P – Avax Sa’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about J&P – Avax Sa, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of J&P – Avax Sa and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess J&P – Avax Sa as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on J&P – Avax Sa’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
J&P – Avax SA: Company Overview
J&P – Avax SA: Overview and Key Facts
J&P – Avax SA: Overview
J&P – Avax SA: Key Facts
J&P – Avax SA: Key Employees
J&P – Avax SA: Major Products and Services
J&P – Avax SA: Company History
J&P – Avax SA: Management Statement
J&P – Avax SA: Locations and Subsidiaries
J&P – Avax SA: Key Competitors
J&P – Avax SA: Company Analysis
J&P – Avax SA: Business Description
J&P – Avax SA: SWOT Analysis
J&P – Avax SA: SWOT Overview
J&P – Avax SA: Strengths
J&P – Avax SA: Weaknesses
J&P – Avax SA: Opportunities
J&P – Avax SA: Threats
J&P – Avax SA: Recent Developments
J&P – Avax SA: News and Events Summary
J&P – Avax SA: Contracts
J&P – Avax SA: Corporate Governance
J&P – Avax SA: Financial Deals
J&P – Avax SA: Regulatory and Legal Events
J&P – Avax SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: J&P - Avax SA: Key Facts
Table 2: J&P - Avax SA: Key Employees
Table 3: J&P - Avax SA: Company History
Table 4: J&P - Avax SA: Locations and Subsidiaries
Table 5: J&P - Avax SA: Key Competitors
Table 6: J&P - Avax SA: News and Events Summary
Table 7: J&P - Avax SA: Contracts
Table 8: J&P - Avax SA: Corporate Governance
Table 9: J&P - Avax SA: Financial Deals
Table 10: J&P - Avax SA: Regulatory and Legal Events
Table 11: J&P - Avax SA: Strategy and Operations

★海外企業調査レポート[J&P – Avax Sa:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Recordati S.p.A.:企業のM&A・事業提携・投資動向
    Recordati S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recordati S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petro …
  • Anika Therapeutics Inc (ANIK)-医療機器分野:企業M&A・提携分析
    Summary Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products i …
  • NIH Office of Technology Transfer-製薬・医療分野:企業M&A・提携分析
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Baytex Energy Corp (BTE):企業の財務・戦略的SWOT分析
    Baytex Energy Corp (BTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Zeria Pharmaceutical Co Ltd (4559):企業の財務・戦略的SWOT分析
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • Pierrel Spa (PRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • PolyPid Ltd:製品パイプライン分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • Dana Petroleum Ltd:企業の戦略的SWOT分析
    Dana Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • LG Chem Ltd (051910):企業の財務・戦略的SWOT分析
    LG Chem Ltd (051910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dalian Port (PDA) Co Ltd (2880):石油・ガス:M&Aディール及び事業提携情報
    Summary Dalian Port (PDA) Co Ltd (Dalian), a subsidiary of Dalian Port Corp Ltd is an oil and gas company that offers port and logistic services. The company offers services such as passenger and roll-on, roll-off terminal, bulk grain terminal, and related logistics services. It also provides oil an …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • KKR Financial Holdings LLC:企業の戦略・SWOT・財務情報
    KKR Financial Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary KKR Financial Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • scPharmaceuticals Inc (SCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary ScPharmaceuticals Inc (scPharmaceuticals) is a clinical-stage pharmaceutical company. The company’s pipeline products include subcutaneous formulations of furosemide, ceftriaxone and carbapenem. Its furosemide formulation is a loop diuretic widely used in prescription pharmaceuticals for the …
  • Turisthotel d.d.:企業の戦略・SWOT・財務情報
    Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report Summary Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ProteoMediX AG:製品パイプライン分析
    Summary ProteoMediX AG (ProteoMediX) is a medical diagnostic company which identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • Apex Healthcare Berhad (AHEALTH):企業の財務・戦略的SWOT分析
    Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆